Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis
Krzysztof Leśniewski-Kmak,В. Моисеенко,Mark Saunders,Harpreet Wasan,Guillem Argilés,Christophe Borg,Geert‐Jan Creemers,M. Fedyanin,Rob Glynne‐Jones,Per Pfeiffer,Cornelis J.A. Punt,Daniil Stroyakovskiy,A ten Tije,A. van de Wouw,Akira Kanehisa,Ronan Fougeray,Natividad Lopez Busto,Nadia Amellal,Eric Van Cutsem
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
无极微光
Twonej
niNe3YUE
你嵙这个期刊没买
YifanWang
pluto
优美紫槐
风清扬
null
Moonpie
tuanheqi
轨迹
wanci
幽壑之潜蛟
寻道图强
smottom
HOAN
小莨
专注的问寒
劉浏琉
wy.he
BowieHuang
spc68
皖公网安备34019202002308
